Standout Papers

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer 2022 2026 2023 2024152
  1. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer (2022)
    Julien Bezin, Amandine Gouverneur et al. Diabetes Care

Immediate Impact

12 standout
Sub-graph 1 of 6

Citing Papers

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
2024 Standout
1 intermediate paper

Works of Clément Mathieu being referenced

GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
2022 Standout
First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective
2021

Author Peers

Author Last Decade Papers Cites
Clément Mathieu 4 28 8 124 78 10 224
Melvin Munsaka 3 50 149 67 12 288
Jingyue Huang 4 13 135 55 11 193
Sheriza Baksh 4 8 2 115 58 11 172
D.B. Jefferys 5 9 53 28 15 248
Kyaw Soe 8 11 3 109 39 18 206
Fiona Ivison 5 5 1 166 71 13 289
Ignazio Verzicco 1 36 1 24 43 14 230
Chrysanthi Mantsiou 14 10 4 159 79 11 292
Caroline Holm Nørgaard 4 11 171 61 10 278
Norimi Ohashi 12 9 88 75 13 274

All Works

Loading papers...

Rankless by CCL
2026